USPL1

Chr 13

ubiquitin specific peptidase like 1

Also known as: C13orf22, D13S106E, bA121O19.1

Enables SUMO binding activity and deSUMOylase activity. Involved in several processes, including Cajal body organization; protein desumoylation; and snRNA transcription. Located in Cajal body. [provided by Alliance of Genome Resources, Jul 2025]

ResearchGenerating clinical summary…

Clinical highlights

Interpreting a novel variant
This gene is strongly intolerant of loss-of-function variation in the population, so LoF variants warrant close attention. No curated mechanism annotation is available — see the mechanism card for the computational prediction and its caveats.Based on population constraint only.
0
Active trials
3
Pubs (1 yr)
—
P/LP submissions
—
P/LP missense
0.46
LOEUF
—
Mechanism
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.46LOEUF
pLI 0.022
Z-score 4.24
OE 0.28 (0.17–0.46)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
0.43Z-score
OE missense 0.95 (0.88–1.02)
528 obs / 556.4 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.28 (0.17–0.46)
0≤0.351.4
Missense OE?0.95 (0.88–1.02)
0≤0.61.4
Synonymous OE?1.00
0≤1.21.6
LoF obs/exp: 11 / 39.9Missense obs/exp: 528 / 556.4Syn Z: 0.05

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

USPL1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →